Buy Herti 440 Trastuzumab

Herti 440 contains trastuzumab, a monoclonal antibody used in cancer therapy. This 440mg vial supports targeted treatment protocols. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance for use.

Strength

440mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Hetero Biopharma Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Trastuzumab, the active ingredient in Herti 440, is used to treat certain types of breast and stomach cancers that overexpress the HER2 protein. It works by targeting cancer cells specifically, helping to slow or stop their growth. This medication is often prescribed alongside chemotherapy or other cancer treatments. Patients and caregivers often ask, what is trastuzumab used for in cancer care.

Side Effects

Herti 440 may cause side effects such as fever, chills, or weakness, especially during the first infusion. Some people experience nausea, vomiting, or headaches. These effects are usually temporary and monitored by healthcare providers. Severe reactions are rare but require immediate medical attention.

Precautions & Warnings

Herti 440 should be handled and administered by trained medical professionals. Keep vials refrigerated between 2-8°C and protect from light. Do not freeze or shake the vial. Always check the vial for particles or discoloration before use. Patients should report any unusual symptoms to their healthcare team promptly.

Avoid Interactions

Trastuzumab may interact with other medications, including chemotherapy drugs and certain heart medications. Combining it with anthracyclines can increase heart-related side effects. Patients should inform their doctor about all medications, supplements, or herbal products they are taking. Alcohol use may also affect treatment tolerance.

References

Frequently Asked Questions

Trastuzumab is used to treat HER2-positive breast and stomach cancers by targeting cancer cells.

Herti 440 is given as an intravenous infusion by healthcare professionals in a clinical setting.

Common side effects include fever, chills, nausea, and weakness, especially during the first infusion.

Trastuzumab must be prescribed and administered under medical supervision; online availability varies by region.

Store Herti 440 vials refrigerated between 2-8°C and protect from light.

Published by GNH India Pharmaceuticals Limited

Last updated: 18 May 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.